These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 26743338)

  • 1. Factors associated with discontinuation of aripiprazole treatment after switching from other antipsychotics in patients with chronic schizophrenia: A prospective observational study.
    Takaesu Y; Kishimoto T; Murakoshi A; Takahashi N; Inoue Y
    Psychiatry Res; 2016 Feb; 236():71-74. PubMed ID: 26743338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.
    Takase M; Kanahara N; Oda Y; Kimura H; Watanabe H; Iyo M
    J Psychopharmacol; 2015 Apr; 29(4):383-9. PubMed ID: 25735995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate vs Gradual Discontinuation in Antipsychotic Switching: A Systematic Review and Meta-analysis.
    Takeuchi H; Kantor N; Uchida H; Suzuki T; Remington G
    Schizophr Bull; 2017 Jul; 43(4):862-871. PubMed ID: 28044008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole as protector against COVID-19 mortality.
    Loucera-Muñecas C; Canal-Rivero M; Ruiz-Veguilla M; Carmona R; Bostelmann G; Garrido-Torres N; Dopazo J; Crespo-Facorro B
    Sci Rep; 2024 May; 14(1):12362. PubMed ID: 38811612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review.
    Karson C; Duffy RA; Eramo A; Nylander AG; Offord SJ
    Neuropsychiatr Dis Treat; 2016; 12():57-67. PubMed ID: 26792993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia.
    Harvey RC; James AC; Shields GE
    CNS Drugs; 2016 Jan; 30(1):27-39. PubMed ID: 26801655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACP Journal Club. In older adults with treatment-resistant depression, adding aripiprazole to venlafaxine increased remission at 12 wk.
    Hategan A
    Ann Intern Med; 2016 Jan; 164(2):JC10. PubMed ID: 26784490
    [No Abstract]   [Full Text] [Related]  

  • 8. Brexpiprazole for the Treatment of Schizophrenia: A Review of this Novel Serotonin-Dopamine Activity Modulator.
    McEvoy J; Citrome L
    Clin Schizophr Relat Psychoses; 2016; 9(4):177-86. PubMed ID: 26757416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study.
    Lodhi RJ; Masand S; Malik A; Shivakumar K; McAllister VD; O'Keane V; Young LC; Heald AH; Sherwood RA; Aitchison KJ
    Schizophr Res; 2016 Feb; 170(2-3):245-51. PubMed ID: 26792297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists.
    Fagiolini A; Alfonsi E; Amodeo G; Cenci M; Di Lella M; Farinella F; Ferraiuolo F; Fraguas D; Loparco N; Gutierrez-Rojas L; Mignone ML; Pataracchia G; Pillai G; Russo F; Sanchez-Gistau V; Spinogatti F; Toscano M; Villari V; De Filippis S
    Expert Opin Drug Saf; 2016; 15(4):449-55. PubMed ID: 26886162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone.
    Qiao Y; Yang F; Li C; Guo Q; Wen H; Zhu S; Ouyang Q; Shen W; Sheng J
    Psychiatry Res; 2016 Mar; 237():83-9. PubMed ID: 26921057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive remission: a novel objective for the treatment of major depression?
    Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF
    BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.
    Galling B; Roldán A; Rietschel L; Hagi K; Walyzada F; Zheng W; Cao XL; Xiang YT; Kane JM; Correll CU
    Expert Opin Drug Saf; 2016 May; 15(5):591-612. PubMed ID: 26967126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole long-acting injection: promising but more evidence needed.
    Keks NA; Hope J; Culhane C
    Australas Psychiatry; 2016 Aug; 24(4):368-70. PubMed ID: 26906437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept Studies.
    Macaluso M; Flynn A; Preskorn S
    J Psychiatr Pract; 2016 Jan; 22(1):42-9. PubMed ID: 26813487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis.
    Hollis C; Pennant M; Cuenca J; Glazebrook C; Kendall T; Whittington C; Stockton S; Larsson L; Bunton P; Dobson S; Groom M; Hedderly T; Heyman I; Jackson GM; Jackson S; Murphy T; Rickards H; Robertson M; Stern J
    Health Technol Assess; 2016 Jan; 20(4):1-450, vii-viii. PubMed ID: 26786936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for tic disorders: An overview of systematic reviews and meta analyses.
    Yang C; Hao Z; Zhu C; Guo Q; Mu D; Zhang L
    Neurosci Biobehav Rev; 2016 Apr; 63():239-55. PubMed ID: 26751711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and Tolerability of Aripiprazole in Children and Adolescents with Tourette's Disorder: A Meta-Analysis.
    Liu Y; Ni H; Wang C; Li L; Cheng Z; Weng Z
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):436-41. PubMed ID: 26914764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics.
    Spina E; Pisani F; de Leon J
    Pharmacol Res; 2016 Apr; 106():72-86. PubMed ID: 26896788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole Use in Children Diagnosed with Down Syndrome and Comorbid Autism Spectrum Disorders.
    Bacanli A
    J Child Adolesc Psychopharmacol; 2016 Apr; 26(3):306-8. PubMed ID: 26870907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.